The results so far in the modern vaccine trials are promising. The vaccine has been shown to produce antibodies that kill the virus, even in the elderly. The level of these antibodies is also reported to be the same as in young people. Researchers also say that cats need to be included in any precautionary measures against the virus.
Their research was published in the New England Journal of Medicine. Research has shown that the vaccine works well even in the elderly who are at high risk of contracting the virus.
Dr. Evan Anderson, who led the research, said the results were promising. It was conducted as a continuation of the Phase1 research conducted by Moderna on those between the ages of 18-55.
Classified into two doses and administered. 25 micrograms under one dose .. 100 micrograms were consumed under the second dose. Age 56-70, 71, and then selected them as another group. It was applied to a total of 40 people. 100 micrograms were applied 28 days apart on adults over 71 years of age. Of whom antibodies are produced on par with youth